Skip to main content

Security report for parexel.com

Parexel International (MA) Corporation · Healthcare · United States

Medium risk. 2 critical or high findings in GDPR outside view and SSL/TLS.

Security score

69/100

Risk levelMedium

0–100, higher is better. How it is calculated

Parexel International is a leading global Contract Research Organization (CRO) specializing in clinical development services for the biopharmaceutical industry. With over 24,000 professionals worldwide, Parexel offers comprehensive solutions spanning Phase I to IV clinical trials, regulatory strategy, and patient engagement. The company positions itself as a trusted partner to biopharmaceutical leaders and clinical trial sites, emphasizing patient-centric trial design and execution. The website reflects a mature digital presence with rich content, clear navigation, and strong branding consistency. Technically, the site leverages Concrete CMS, integrates modern analytics and marketing tools, and employs robust security measures including HTTPS and security headers. Privacy compliance is well addressed with comprehensive policies and a granular cookie consent mechanism. Overall, Parexel's website demonstrates a high level of professionalism, trustworthiness, and operational maturity.

Scanned

NIS2 and GDPR posture

GDPR outside view
63/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

2 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • Critical

      No HTTPS encryption

      GDPR requires appropriate security measures for personal data

      What to do: Implement SSL/TLS certificate for HTTPS

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • Critical

      No HTTPS Encryption

      Website does not use HTTPS encryption, making all data transmission vulnerable to interception

      What to do: Implement SSL/TLS certificate and redirect all HTTP traffic to HTTPS

Need hands-on remediation? Email guard@offseq.com

Keep watching parexel.com

This scan found 12 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
0
Security headers
80
Email security
85
DNS health
85
Network security
100
GDPR outside view
63
Average
69

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Parexel holds a strong market position as one of the largest CROs globally, serving biopharmaceutical companies with a broad portfolio of clinical development services. Their business model focuses on B2B partnerships, supported by a global workforce and specialized therapeutic expertise. The company maintains a diverse ecosystem of partner sites and resources, including a newsroom, academy, and career portal. Their content strategy targets industry professionals and patients, highlighting patient stories and therapeutic innovations. The presence of compliance, ethics, and privacy pages underscores a commitment to regulatory adherence and corporate responsibility. The domain age and WHOIS data corroborate the company's established history and legitimacy.

Security posture

The website exhibits a strong security posture with enforced HTTPS, presence of key security headers, and no visible exposure of sensitive data. The use of third-party security services like Imperva Incapsula adds an additional layer of protection. Cookie consent is managed via CookiePro, providing users with control over tracking preferences. No critical vulnerabilities or security misconfigurations were detected in the HTML content. However, the absence of a public vulnerability disclosure policy or security.txt is noted as an area for improvement. Incident response contact information is not explicitly provided, which could enhance transparency and readiness.

Recommendations

  1. Implement and publish a vulnerability disclosure policy or security.txt file to facilitate responsible reporting.
  2. Consider adding explicit incident response contact channels such as security@ or abuse@ email addresses.
  3. Regularly audit and update third-party libraries and scripts to mitigate potential vulnerabilities.
  4. Enhance security policy documentation by referencing recognized frameworks like ISO 27001 or NIST.
  5. Maintain continuous monitoring of security headers and SSL/TLS configurations to uphold best practices.

Contact details published on the site

Addresses
Legal name
Parexel International (MA) Corporation
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Parexel International (MA) Corporation
Description
Parexel is a global Contract Research Organization (CRO) providing a full range of Phase I to IV clinical development services, leveraging clinical, regulatory, and therapeutic expertise to partner with biopharmaceutical leaders and sites to design and deliver clinical trials with patient focus.
Key services
Clinical development services, Portfolio management and asset valuation, Early development and innovation, Integrated clinical development, Approval and access, Value substantiation lifecycle management, Medical affairs, Operational excellence, Biotech clinical trial solutions
Content quality
excellent
Branding
consistent

Technology

Stack
jQuery, Google Tag Manager, Google Analytics, Concrete CMS, CookiePro Consent Management, Bugherd, Instabot
Performance
moderate
Mobile
good
Accessibility
good
SEO
good

Security

Observed score
90/100
Good practices seen
  • HTTPS enforced
  • Cookie consent banner with granular controls
  • No exposed sensitive data in HTML
  • Use of security headers
  • Use of third-party security services (Incapsula)

Analytics and tracking

Services
Google Analytics, Google Tag Manager
Tracking level
moderate
Privacy practices
good

Advertising

Marketing tools
Instabot
Transparency
good

Site quality

Design
excellent
User experience
excellent
Content relevance
excellent
Navigation
excellent
Professionalism
excellent
Trustworthiness
high

Key observations

  1. Website is professionally designed and well-structured.
  2. Comprehensive privacy and cookie policies with consent management.
  3. Multiple external trusted links to company resources and social media.
  4. Use of modern tracking and marketing tools with privacy controls.
  5. No signs of blocking or WAF challenges.
  6. Strong security posture with HTTPS and security headers.
  7. Clear business and contact information provided.
  8. Content is rich, relevant, and targeted to biopharmaceutical industry stakeholders.
Technical notes

Notes

The website is built on Concrete CMS and utilizes a modern tech stack including jQuery, Google Tag Manager, and CookiePro for consent management. Hosting is provided via Imperva Incapsula, indicating enterprise-grade security and performance infrastructure. The site demonstrates good mobile optimization and accessibility features, with well-structured navigation and SEO-friendly meta tags. Performance is moderate, with potential for optimization in script loading and resource management. The integration of marketing and analytics tools is balanced with privacy compliance. Overall, the technical implementation supports the business goals effectively while maintaining a secure and user-friendly environment.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with parexel.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review parexel.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.